Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Community acquired pneumonia. A perspective for general practice.

E Tsirgiotis1, R Ruffin

  • 1Department of Respiratory Medicine, North Western Adelaide Health Service, South Australia.

Australian Family Physician
|July 29, 2000
PubMed
Summary

Community acquired pneumonia (CAP) affects 2 in 1000 adults annually. Early antibiotic treatment and vaccinations can reduce CAP incidence and mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prevalence of depression in the North West Adelaide Health Study.

Acta neuropsychiatrica·2016
Same author

Depression and health risk factors in the North West Adelaide Health Study.

Acta neuropsychiatrica·2016
Same author

Peak expiratory flow (PEF) monitoring.

Thorax·2004
Same author

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.

The European respiratory journal·2002
Same author

Home care by outreach nursing for chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews·2001
Same author

Automated attention flags in chronic disease care planning.

The Medical journal of Australia·2001

Area of Science:

  • Internal Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Community acquired pneumonia (CAP) affects approximately 2 per 1000 adults yearly.
  • CAP accounts for 2% of adult hospital admissions with a 7-10% mortality rate.

Purpose of the Study:

  • To outline a comprehensive approach for assessing and managing CAP in both community and hospital settings.
  • To integrate current evidence and concepts into CAP management strategies.

Main Methods:

  • Review of current concepts and evidence for CAP assessment and management.
  • Emphasis on clinical severity assessment and patient risk profiling.
  • Guideline-based early antibiotic therapy and supportive care.

Main Results:

  • Clinical and radiological assessments cannot definitively identify the causative organism in CAP.
  • Patient risk profile and clinical severity are crucial for guiding management decisions.
  • Early, guideline-adherent antibiotic therapy and supportive care are vital for reducing mortality.

Conclusions:

  • Effective CAP management relies on risk stratification and severity assessment, not solely on pathogen identification.
  • Prompt antibiotic administration and supportive measures are key to reducing CAP mortality.
  • Vaccination against pneumococcal and influenza pathogens can decrease CAP incidence.

Related Experiment Videos